Pila Pharma Overview

  • Founded
  • 2014

Founded
  • Status
  • Public

  • Employees
  • 3

Employees
  • Stock Symbol
  • PILA

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.27

  • (As of Monday Closing)

Pila Pharma General Information

Description

Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Västergatan 1
  • 211 21 Malmo
  • Sweden
+46 073-903 00 00

Pila Pharma Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pila Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.27 $0.26 $0.18 - $0.55 $4.86M 18.4M 9.2K $0.06

Pila Pharma Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 4,232 8,371
Revenue 197 84 0 37
EBITDA (1,657) (1,998) (755) (914)
Net Income (1,657) (2,004) (757) (917)
Total Assets 780 3,515 654 850
Total Debt 0 0 61 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pila Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pila Pharma‘s full profile, request access.

Request a free trial

Pila Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel ty
Drug Discovery
Malmo, Sweden
3 As of 2022
000
00.00 0000-00-00
00000000 000

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
0000000000000
Cambridge, MA
0000 As of 0000
000.00
000 0000-00-00
000000&0

000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incid
0000000000000
Bengaluru, India
00000 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pila Pharma Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biogen Formerly VC-backed Cambridge, MA 0000 000.00 000000&0
000000 Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
000000 00000000000 Corporation Boston, MA 00 000.00 000000000000 000.00
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 0000000000
You’re viewing 5 of 10 competitors. Get the full list »

Pila Pharma Executive Team (5)

Name Title Board Seat Contact Info
Dorte Gram Ph.D Founder, Chief Executive Officer & Board Member
Elna Åström Chief Financial Officer
Gustav Gram Manager of Investor Relations
You’re viewing 3 of 5 executive team members. Get the full list »

Pila Pharma Board Members (10)

Name Representing Role Since
Dorte Gram Ph.D Pila Pharma Founder, Chief Executive Officer & Board Member 000 0000
Fredrik Buch MD Self Chairman 000 0000
Lene Andersen Pila Pharma Board Member 000 0000
Milan Zdravkovic Ph.D Self Board Member 000 0000
Tyge Korsgaard Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Pila Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pila Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pila Pharma‘s full profile, request access.

Request a free trial

Pila Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 27-Sep-2016 00000 0000 00.000 Drug Discovery
Ario Pharma (TRPV1 antagonist asset) 30-Mar-2016 Corporate Asset Purchase Buildings and Property 00000 000
To view Pila Pharma’s complete investments history, request access »